Search results
136 Results for 'James J. Collins'
- Technologies (11)
- Collaborations (1)
- Team (0)
- News (94)
- Pages (0)
- Multimedia (21)
- Publications (0)
- Jobs (0)
- Events (9)
Technologies 11
-
Instrument-Free Molecular Diagnostics
A synthetic biology-based molecular diagnostics platform that enables the creation of low-cost, highly accurate tests for non-clinical settings. -
AminoX: Making Better Protein Drugs, Quicker and Cheaper
AminoX enables protein drugs to only become active in the tumor microenvironment and not elsewhere in the body to avoid immune-related adverse effects in the body. By designing and building non-standard amino acids into strategic positions of protein drugs, AminoX provides tumor-specific, and longer-lasting target inhibition. -
Engineered Live Biotherapeutic Product (eLBP) to Protect the Microbiome from Antibiotics
eLBP is a safe and cost-effective therapeutic for patients treated with beta-lactam antibiotics that safeguards against the loss of health-essential microbes while preventing the development and spread of antibiotic resistance. -
Paper-Based Diagnostics
With the imminent threat of new pandemics and frequent disease outbreaks exemplified by the recent Ebola and Zika epidemics, there is a growing need for low-cost, easily deployable and simple-to-use diagnostic tools. The Wyss Institute has developed paper-based synthetic gene networks as a next generation diagnostic technology for use in global healthcare crises and patient... -
Sugar-to-Fiber Enzyme for Healthier Food
In collaboration with Kraft Heinz, our sugar-to-fiber product can convert sugar in food products into prebiotic fiber in the human gut, reducing the amount of sugar absorbed into the bloodstream without altering the amount of sugar in existing food product recipes. -
Sparkle: Instant Biosensors for Real-Time Imaging
Sparkle is revolutionizing the binder assay industry by harnessing novel chemistry to create instant fluorescent biosensors for a wide variety of uses.
Collaborations 1
News 94
Multimedia 21
-
Video/AnimationAminoX: Making Better Protein Drugs, Quicker and CheaperA synthetic biology and advanced chemistry platform that efficiently incorporates non-standard amino acids by hacking the ubiquitous protein synthesis process. Credit: Wyss Institute at Harvard University
-
Audio/PodcastIdeas to Innovation – From Lab to Life: The Transformative Power of Synthetic BiologyRapid advancements in technology and science are shaping a new era, with artificial intelligence and synthetic biology, or “syn-bio,” at the forefront. Heralded as the next big leap in science, syn-bio involves redesigning organisms for useful purposes by engineering them to have new abilities. The importance of syn-bio for people and our planet cannot be...
-
Video/AnimationNucleoTide – CRISPR-based biosensors for rapidly detecting harmful marine microbesThe warming of the oceans due to climate change has increased the frequency and potency of harmful algal blooms. These algae species produce toxins that can harm or even kill people, fish, shellfish, marine mammals, and birds. Researchers at the Wyss Institute are working to develop inexpensive sensors that could detect dangerous algae species earlier...
-
Audio/PodcastTranslating SynBio with Jim CollinsThe BIOS Podcast by Alix Ventures features experts and thought leaders in healthcare & life sciences. We bring you cutting-edge insights from executives, investors, founders, scientists, academics, and more. BIOS is a community of early stage healthcare and life sciences founders and investors. It is anchored by Alix Ventures, a San Francisco-based venture fund that invests in early stage...
-
Video/AnimationeToehold: an RNA-detecting control element for use in RNA therapeutics, diagnostics and cell therapiesThis animation shows an example of an eToehold that detects and signals the presence of a specific viral RNA in a human cell. After the virus has injected its RNA into a host cell, the RNA acts as a “trigger RNA” by binding to a complementary sequence within the eToehold specifically engineered for its detection....
-
Video/AnimationmiSherlock – Detecting COVID-19 Variants from SalivaDespite increasing vaccination rates, new, more-infectious variants of SARS-CoV-2 could prolong the COVID-19 pandemic. Researchers at the Wyss Institute at Harvard University and MIT have created a low-cost, CRISPR-based diagnostic platform that can detect SARS-CoV-2 variants in a patient’s saliva without the need for any additional equipment. The team hopes their device will enable more...
Events 9
-
Sep 20, 2019, 8:20am - 6:00pmWyss Event
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
The 10th International Wyss Institute Symposium will focus on Next-Generation Diagnostics; convening the Institute’s vast network of collaborators, students, researchers, faculty and clinicians alongside industrial researchers, and members of academic institutions and foundations leading the development of diagnostics technology. This year’s Symposium will highlight the latest developments of this emerging field and address the need... Free and open to public -
Jun 3, 2019, 1:00pm - 2:00pmLecture
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
Wyss Core Faculty member James J. Collins will be speaking at a Brigham and Women’s Pathology Grand Rounds event on Monday, June 3 from 1 PM to 2 PM. The topic is, “Point of care diagnostics based on synthetic biology.” Accreditation Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education... Free and open to public -
Feb 26, 2019, 1:00pm - 2:00pmLecture
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
On Tuesday, February 26, join Brigham and Women’s Hospital for the weekly Clinical Pathology Conference lecture series featuring Wyss Core Faculty member James Collins. James Collins is a founder of the field of synthetic biology and a pioneer in the application of systems biology concepts to solve major biomedical problems. His internationally acclaimed research uses network... Free and open to public